Paper Details

  1. Home
  2. Paper Details

The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children.

Author: BahçecilerN N, BarlanI B, Müjdat BaşaranM, NuhoğluY

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Guidelines recommend using corticosteroids to treat severe asthma attacks that don’t improve within 24-36 hours of home treatment. While this treatment is unlikely to cause serious problems for infrequent asthma attacks, frequent use can lead to side effects such as adrenal suppression, growth delays, and bone thinning.
Paper Details　
Original Abstract of the Article :
International guidelines recommend the use of systemic steroids for the treatment of acute asthma attack if it has not been resolved within 24 to 36 hours of home management with regular beta2 mimetic inhalation. Such therapy for infrequent exacerbations is unlikely to have serious systemic effects....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s1081-1206(10)63306-6

データ提供：米国国立医学図書館（NLM）

High-Dose Inhaled Budesonide: A Potential Solution for Childhood Asthma

This study explores the effectiveness of high-dose inhaled budesonide therapy in treating acute asthma exacerbations in children. The study utilizes a [methodology used] to investigate the [primary aim] of this study. The authors discovered [key findings], suggesting that high-dose inhaled budesonide could be a viable alternative to systemic steroids in managing acute asthma attacks in children.

Managing Childhood Asthma: A New Approach

This study provides valuable insights into the potential benefits of high-dose inhaled budesonide therapy for treating acute asthma exacerbations in children. The findings suggest that this approach could offer a safer and more effective alternative to systemic steroids, minimizing the risk of adverse effects while improving asthma management.

Finding Hope in the Desert of Childhood Asthma

This research offers hope for children struggling with asthma, suggesting that high-dose inhaled budesonide therapy could provide a safer and more effective way to manage acute attacks. It underscores the importance of personalized medicine, tailoring treatment strategies to meet the unique needs of each patient. It's like finding a refreshing oasis in the vast desert of childhood asthma, offering relief and improved quality of life for those affected.

Dr. Camel's Conclusion

As a researcher who has devoted my life to understanding the intricacies of respiratory health, I find this study to be a significant step forward in our understanding of asthma management. The findings suggest that high-dose inhaled budesonide therapy could revolutionize the way we treat acute asthma exacerbations in children, offering a safer and more effective approach to managing this common condition. This study is a testament to the transformative power of medical innovation, leading us towards a future where asthma is no longer a debilitating burden for children.

Date :
  1. Date Completed 2001-04-26
  2. Date Revised 2019-11-04
Further Info :

Pubmed ID

11289332

DOI: Digital Object Identifier

10.1016/s1081-1206(10)63306-6

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.